Liver function may change how anxiety drug works in body
NCT ID NCT07457190
First seen Apr 09, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This early-stage study looks at how the body processes buagafuran, an experimental anxiety drug, in people with liver impairment compared to those with normal liver function. About 24 adults will take a single dose and have their blood levels and safety monitored. The goal is to understand if liver problems affect drug breakdown, not to treat anxiety directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Union Pharmaceutical Factory Ltd
Beijing, Beijing Municipality, 102600, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.